Skip to main content
. 2020 Aug 26;10:1404. doi: 10.3389/fonc.2020.01404

Table 4.

Immune-related adverse events.

Adverse event Grade 1/2 Grade 3/4 Patients, n (%)
Chemotherapy TKIs treatment Chemotherapy TKIs treatment
Mucositis 0 1 0 0 1 (4.5%)
Hypothyroidism 1 2 0 1 4 (18.2%)
Fatigue 1 2 0 0 1 (4.5%)
Diarrhea 1 1 0 0 2 (9.1%)
Hypophysitis 1 1 0 0 2 (9.1%)
Anorexia 1 1 0 0 2 (9.1%)
Albuminuria 0 1 0 0 1 (4.5%)
Hyperbilirubinemia 0 1 0 0 1 (4.5%)